Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Greuter

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
Digestive Diseases (Basel, Switzerland)|June 9, 2017
Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III SurveyStephan R Vavricka, Milos Spasojevic, Gerhard Rogler, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 25, 2020
GIPC-Regulated IGFBP-3 Promotes HSC Migration In Vitro and Portal Hypertension In Vivo Through a β1-Integrin PathwayUsman Yaqoob, Fanghong Luo, Thomas Greuter, et al.
Journal of Crohn'S & Colitis|November 29, 2017
Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel DiseaseStephan R Vavricka, Jose A Galván, Heather Dawson, et al.
European Journal of Gastroenterology & Hepatology|February 1, 2018
Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease CohortSébastien Godat, Nicolas Fournier, Ekaterina Safroneeva, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 31, 2016
The perspective of celiac disease patients on emerging treatment options and non-celiac gluten sensitivityThomas Greuter, Sandra Schmidlin, Jaqueline Lattmann, et al.
International Archives of Allergy and Immunology|September 20, 2021
Systematic Review of Outcome Measures Used in Observational Studies of Adults with Eosinophilic EsophagitisAlain M Schoepfer, Camilla Schürmann, Sven Trelle, et al.
International Archives of Allergy and Immunology|October 22, 2023
Histological Phenotyping in Eosinophilic Esophagitis: Localized Proximal Disease Is Infrequent but Associated with Less Severe Disease and Better Disease OutcomeAlexis Heil, Tobias Kuehlewindt, Anne Godat, et al.
Journal of Clinical Gastroenterology|September 17, 2016
Celiac Disease is Misdiagnosed Based on Serology Only in a Substantial Proportion of PatientsStephan R Vavricka, Teresa Stelzer, Jaqueline Lattmann, et al.
Plos One|September 16, 2022
Effect of closed and permanent stoma on disease course, psychological well-being and working capacity in Swiss IBD cohort study patientsRahel Bianchi, Barry Mamadou-Pathé, Roland von Känel, et al.
Gut|January 6, 2026
Role of A2 beta casein in milk-induced eosinophilic oesophagitis: novel in-vivo and in-vitro findingsAlex Straumann, Emilie Gueguen, Andrea Kreienbühl, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
Digestive Diseases (Basel, Switzerland)|June 9, 2017
Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III SurveyStephan R Vavricka, Milos Spasojevic, Gerhard Rogler, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 25, 2020
GIPC-Regulated IGFBP-3 Promotes HSC Migration In Vitro and Portal Hypertension In Vivo Through a β1-Integrin PathwayUsman Yaqoob, Fanghong Luo, Thomas Greuter, et al.
Journal of Crohn'S & Colitis|November 29, 2017
Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel DiseaseStephan R Vavricka, Jose A Galván, Heather Dawson, et al.
European Journal of Gastroenterology & Hepatology|February 1, 2018
Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease CohortSébastien Godat, Nicolas Fournier, Ekaterina Safroneeva, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 31, 2016
The perspective of celiac disease patients on emerging treatment options and non-celiac gluten sensitivityThomas Greuter, Sandra Schmidlin, Jaqueline Lattmann, et al.
International Archives of Allergy and Immunology|September 20, 2021
Systematic Review of Outcome Measures Used in Observational Studies of Adults with Eosinophilic EsophagitisAlain M Schoepfer, Camilla Schürmann, Sven Trelle, et al.
International Archives of Allergy and Immunology|October 22, 2023
Histological Phenotyping in Eosinophilic Esophagitis: Localized Proximal Disease Is Infrequent but Associated with Less Severe Disease and Better Disease OutcomeAlexis Heil, Tobias Kuehlewindt, Anne Godat, et al.
Journal of Clinical Gastroenterology|September 17, 2016
Celiac Disease is Misdiagnosed Based on Serology Only in a Substantial Proportion of PatientsStephan R Vavricka, Teresa Stelzer, Jaqueline Lattmann, et al.
Plos One|September 16, 2022
Effect of closed and permanent stoma on disease course, psychological well-being and working capacity in Swiss IBD cohort study patientsRahel Bianchi, Barry Mamadou-Pathé, Roland von Känel, et al.
Gut|January 6, 2026
Role of A2 beta casein in milk-induced eosinophilic oesophagitis: novel in-vivo and in-vitro findingsAlex Straumann, Emilie Gueguen, Andrea Kreienbühl, et al.
Pageof 14